Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public
health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date …

Rapid diagnosis of infectious diseases and timely initiation of appropriate treatment are
critical determinants that promote optimal clinical outcomes and general public health …

This guideline offers recommendations on the diagnostic tests, treatment regimens and
health promotion principles needed for the effective management of Chlamydia trachomatis …

Chlamydia trachomatis infections affect young, sexually active persons. Risk factors include
multiple partners and failure to use condoms. The incidence of infection has increased in the …

Accurate and inexpensive point-of-care (POC) tests are urgently needed to control sexually
transmitted infection epidemics, so that patients can receive immediate diagnoses and …

Background Routine screening is key to sexually transmitted infection (STI) prevention and
control. Previous studies suggest that clinic-based screening programmes capture only a …

Background Infection by Chlamydia trachomatis (CT) is the most prevalent sexually
transmitted infection (STI) world wide. The most frequently used diagnostic test for CT is a …

Chlamydia trachomatis (CT) is the most common bacterial cause of sexually transmitted
infections. CT infections are strongly associated with risk-taking behavior …

Objectives To compare the effectiveness and cost-effectiveness of a promising new point-of-
care (POC) chlamydia test with traditional nucleic acid amplification testing (NAAT), and to …

Objectives To estimate the costs and benefits of clinical pathways incorporating a point of
care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in …